Stock Market & Financial Investment News

News Breaks October 4, 2012 05:15 EDT NUVA NuVasive downgraded to Market Perform from Outperform at Wells Fargo Wells Fargo downgraded NuVasive citing a lack of visibility after the company lowered its revenue outlook for Q3. The firm lowered dropped its price target range for shares to $15-$16 from $29-$31. News For NUVA From The Last 14 Days Check below for free stories on NUVA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2013 07:48 EDT NUVA FDA Orthopaedic and Rehabilitation Devices Panel to hold a meeting Subscribe for More Information May 20, 2013 15:53 EDT NUVA NuVasive removed from Best Ideas List at Barrington Barrington removed NuVasive from its Best Ideas List due to recent outperformance but reiterates its Outperform rating. May 17, 2013 10:07 EDT NUVA On The Fly: Analyst Initiation Summary Subscribe for More Information 06:41 EDT NUVA NuVasive initiated with a Buy at WallachBeth Subscribe for More Information May 14, 2013 07:18 EDT NUVA BofA/Merrill to host a conference 2013 Health Care Conference is being held in Las Vegas on May 14-16. Sign up for a free trial to see the rest of the stories you've been missing.